Division of Radiation Health


July 31, 2017

UAMS Researchers Receive $2.9 Million Grant to Study Possible Treatment for Radiation Injury

Ben Boulden

July 31, 2017 | A team of University of Arkansas for Medical Sciences (UAMS) research scientists recently was awarded a $2.97 million, five-year grant by the National Institute of Allergy & Infectious Diseases to investigate a possible treatment for the long-term health effects from injury caused by exposure to high levels of radiation. Marjan Boerma,…


January 17, 2017

Study Shows Chemotherapy Induces Cellular Aging, Which Promotes Side Effects, Cancer Relapse

Ben Boulden

Jan. 17, 2017 | Chemotherapy for cancer causes a pro-inflammatory stress response that promotes adverse side effects and cancer relapse, says a research team that includes the University of Arkansas for Medical Sciences (UAMS). Daohong Zhou, M.D., associate director for basic research in the UAMS Winthrop P. Rockefeller Cancer Institute, is a co-author of the study…


December 14, 2015

UAMS Research Published in Nature Medicine

Ben Boulden

Researchers from the University of Arkansas for Medical Sciences (UAMS) and other institutions are reporting the discovery of the first broad spectrum drug that can potently kill senescent (or aging) cells in culture and effectively clear the cells in animals by specifically targeting a pathway that is critical for the survival of senescent cells. Findings…


June 3, 2014

UAMS Researchers Awarded $4.4 Million Grant for Space Radiation Health Research

Ben Boulden

LITTLE ROCK – A team of University of Arkansas for Medical Sciences (UAMS) research scientists recently was awarded a three-year $4.4 million grant by the National Space Biomedical Research Institute (NSBRI) to investigate the degenerative or long-term health effects of space radiation on cardiovascular health, as part of the newly formed Center for Space Radiation Research.